Company

STH BIOTECH

4, rue Pierre Fontaine – Campus 3
91058 Evry-Courcouronnes Cedex – FRance
Email : h.mailhac@sth-biotech.com

CEO: Héloïse MAILHAC
CTO: Naomi KAMINSKY

Web Site >

Shaker #Industrial Biotech #Biomanufacturing #Health

Plant-based biotechnologies
Active compounds
Cosmetics
Pharmaceutics

Field of Activity

STH BIOTECH is unlocking access to rare plant compounds through plant biotechnology.

BACKGROUND
Founded by two engineers, both graduates of Sup’Biotech and furthermore laureates of the seventh Shaker class in 2020 and the first Gene.IO class in November 2021 and elected Women Rising Innovators by the European Commission in 2025

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
STH BIOTECH develops innovative plant biotechnology processes to make accessible and standardise the production of high added-value plant compounds for the health and cosmetics industries.

ACCOMPLISHMENTS / PARTNERSHIPS / HIGHLIGHTS
STH BIOTECH has been awarded the DeepTech and French Tech Seed labels by Bpi, and was awarded the French Tech Emergence grant in 2022 as well as the Grand Prize in the i-Lab 2023 competition to finance its research programme.

In 2025, STH BIOTECH also won the Innov’Up competition organised by the IDF region.

PARTNERSHIPS SOUGHT
Co-development partnerships pharmaceuticals and cosmetics
Financing

More information

Strengths:

Expertise and innovation capacity in plant biotechnologies, strategic pharmaceutical and cosmetics partnerships

Innovation assets:
Plant-based biotechnology, performance, standardization, sustainability.

Genopole’s Companies

#Industrial Biotech

In the same field

The VERY Food Co

Activity of research, sale, production, distribution and marketing of all unregulated food and agri-food products.

Discover

Synovance

Synovance has developed a revolutionary synthetic genomics platform for the conception of robust industrial bioproduction strains.

Discover

Altar

Ginkgo Bioworks is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover

YposKesi, an SK pharmteco Company

YposKesi (from the Greek Yposchesi, meaning 'promise') is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

Discover

WatchFrog

WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Discover

PHARMING

Pharming specializes in the production of recombinant proteins in transgenic rabbit milk.

Discover

Global Bioenergies

Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.

Discover

Abolis Biotechnologies

Abolis develops custom-order microorganisms able to produce molecules of interest via fermentation for the health, nutrition, chemistry and cosmetics sectors.

Discover

View all >

With the support from